Rawpharma Biz Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.20 M
- Revenue Growth -12.67%
- Profit Growth -600.77%
- Ebitda -271.46%
- Net Worth -9.49%
- Total Assets 66.81%
About Rawpharma Biz
Rawpharma Biz Private Limited (RBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 17 July 2019 (Five years and six months 17 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.20 M.
Rushil Barot and Yashviben Barot serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230GJ2019PTC109137
- Company No.
109137
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Rawpharma Biz Private Limited offer?
Rawpharma Biz Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Inorganic Acids.
Who are the key members and board of directors at Rawpharma Biz?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rushil Barot  | Director | 17-Jul-2019 | Current |
| Yashviben Barot | Director | 17-Jul-2019 | Current |
Financial Performance of Rawpharma Biz.
Rawpharma Biz Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.67% decrease. The company also saw a substantial fall in profitability, with a 600.77% decrease in profit. The company's net worth dipped by a decrease of 9.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rawpharma Biz?
In 2020, Rawpharma Biz had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sbf Pharma Private LimitedRushil Barot is a mutual person
Charges (Loans)
₹5.20 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.52 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2024 | Others | ₹5.20 M | Open |
How Many Employees Work at Rawpharma Biz?
Unlock and access historical data on people associated with Rawpharma Biz, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rawpharma Biz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rawpharma Biz's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.